Information Provided By: 
Fly News Breaks for April 3, 2019
USNA, NUS
Apr 3, 2019 | 07:44 EDT
After Usana (USNA) announced softer than expected preliminary Q1 results, which it attributed to sales in China and unfavorable media coverage on the direct selling industry there, Stifel analyst Mark Astrachan reiterated his Sell rating and $43 price target on shares of competitor Nu Skin (NUS). Despite Nu Skin having less exposure to nutrition than Usana, Astrachan continues to worry about increasing scrutiny on Nu Skin and thinks the potential for a more thorough investigation by the Chinese government remains a risk.
News For NUS;USNA From the Last 2 Days
There are no results for your query NUS;USNA
